Skip to main content

tv   Hearing on U.S. Leadership and International COVID-19 Response  CSPAN  June 10, 2021 4:13pm-5:31pm EDT

4:13 pm
murder and injustice in a small town on his work with the innocent project and wrongful conviction and sunday 9:00 p.m. eastern on "afterwards". former nypd commissioner bill on his book the profession, the more of community, race and policing in america integrated by charles, former philadelphia police commissioner and metropolitan police chief and sunday 10:00 p.m. eastern yale university history professor elizabeth with her book, america on fire. the history of police violence and black rebellion since the 1950s. watch book tv on c-span2 this weekend. ♪♪ >> u.s. government officials talk about global vaccine distribution efforts before house florida affairs subcommittee. >> since the start of the pandemic, nearly 4 million
4:14 pm
people have died from virus and for the first time in years, extreme level poverty is on the rise. global inequality, instability, have all been exacerbated by this pandemic. meanwhile here at home, we are making remarkable progress as you all have witnessed. since president biden's inauguration in the start of this new congress, cases of covid have dramatically decreased from nearly 200,000 new cases on average to less than 15000 cases a day now. american deaths are down from over 4000 early january to less than 500 a day now and continuing to fall. extraordinary progress, thanks to the amick and rescue plan and the american people's commitment, individually and as immunities to defeat this pandemic. with more than 40% of the american people vaccinated, it's clear that vaccines work.
4:15 pm
get the american people are still not secure despite this progress. new and dangerous variants such as the delta there it poses serious threats to our progress here at home. united states must lead to an this pandemic. this congress and this committee have acted by supporting over $10 billion in international and additional development and foreign assistance to end the pandemic at address its effects. we have a vital partner in the biden here's administration in this venture. in april, i said united states of america had to rise to the challenge and become the vaccine arsenal of democracy and provide the world with the tools needed despite covid. as we did during the second world war in the struggle against fascism, i believe we need to leverage our full industrial scientific capacity to manufacture and distribute access vaccines, negotiate a waiver to wto rules in order to
4:16 pm
speed production and reverse losses in the fight against poverty at this pandemic has caused. the covid pandemic has had wide-ranging consequences that we cannot ignore. i want to see the administration's plan, not just response of the crisis on how we build back better. our development work should have gains that are durable and sustainable, reversing the tragic growth and poverty malnutrition and ensuring once in a century pandemics do not become routine occurrences. we need to consider strengthen international organization to play a role in long recovery ahead of us. how they have performed during this crisis were necessary, we need to consider creating new multilateral institutions that reflect post world post pandemic world. united states response to take into account pandemics effects on democratic institutions, like
4:17 pm
victor and hungry will be beyond reasonable health restrictions and use the pandemic to crackdown political opposition. the pandemic has disrupted the workforce of the state department, usaid and allied nations and influencing partners on the pandemic. our infrastructure for diplomacy and development needs to be rebuilt and necessary also reimagined. we need to be open to new ways to reincorporate new technologies new practices. increasing use of tools by development finance in the finance corporation can build a foundation of post pandemic world. we need to consider how we complement the capabilities of our allies and push them also to lead, as i hope president biden will do this week at the g7 summit. i appreciate to make progress in
4:18 pm
these areas including president biden's announcement of at least 80 billion doses for partners around the world with 75% of vaccines to the distribution program kovacs. i also appreciate the focus on vaccinating our neighbors in the western hemisphere, canada, mexico, not in america and caribbean which are deeply interconnected as we all know with the united states. it's a strong start but we are only the beginning of the fight against covered and i look forward to the testimony of our witnesses. i'll turn it over to ranking member mattia took us on her opening remarks. >> thank you, chairman recalling this hearing today and i want to thank jeremy for taking the time to reach the committee. your role in the work you're doing to combat the covid pandemic around the world is critically important.
4:19 pm
3.7 worldwide including for the 595,000 right here in america. even though the u.s. is on a positive trajectory, is devastating many countries around the world. the recent surge in india should be a wake-up call and remark are reminder we all have a long road ahead. i was glad to see the administration announcing moving out vaccine allocations. our partners and allies urgently need this assistance and we must be strategic making these decisions. very concerned by the communist chinese parties effort to exploit countries economic and vaccination needs to secure political confessions. we are seeing this around the world but especially in latin america and caribbean's.
4:20 pm
taiwan's allies have been asked to sever ties with taiwan in exchange for much-needed vaccines. so far, none have agreed but with latin america and caribbean being home to nine, remaining 15 allies, we can expect this trend to continue. i look forward to hearing how the biden administration is addressing these challenges as well as ensuring taiwan has access to vaccines. despite globally threatening this progress. we must prioritize resources to address the impacts of covid especially security, supply chain and the fight against other infectious diseases. this pandemic marks the first increase in global extreme poverty since the 1990s. as the subcommittee oversees
4:21 pm
national development policy and international organization an important role overseeing the administration strategy to support recovery efforts. as i highlighted in the last hearing, this critically important every $8 monitored and evaluated to ensure resources are used effectively and achieves the desired outcome. we need to exploit the pandemic of the biden administration must employ copperheads of aggressive vaccine diplomacy, strategy to help partners in need in advance u.s. strategic interests. i look forward to hearing from witnesses on how the administration plans to utilize funds provided through the plan and how they plan to leverage contributions to ensure other partners step up and do their part. many countries are facing domestic financial hardship, burden sharing among our allies is critical. in closing, i'd be remiss to fail mention working without
4:22 pm
world partners and the origins of the covid pandemic. the only way we will succeed in future pandemics is if we learn the facts on its origin and what actions, if any were taken to prevent proper early containment and i hope this will be a top focus item on the agenda of the g7 this week. i want to thank our witnesses today and i look forward to your testimony. >> thank you ranking member and i'll introduce english witnesses that we have with us today. first is gail smith, coordinator for global corporate response and security of the department of state. she previously served as the 17th administrator for usaid and as president and ceo of the one campaign. we are joined today by mr. jeremy, executive director for the covid task force that usaid want to thank each of you for
4:23 pm
stepping up and serving and being with us today to discuss these issues and speak to what the administration is doing to lead to announcement in the fight against covered and affects around the world. i'll now recognize each witness for five minutes and without objection, your prepared written statements will be made part of the record in our first call on missus smith for her testimony. you have five minutes. >> thank you members of the subcommittee, we are grateful for your calling this hearing and we are extremely grateful for the financial and other support you've provided. if i can set the stage, i got my start in my career almost 40 years ago in the middle of the ethiopian famine. ironically in the middle of a war and since then, i've led, coordinated or been in the field on more than 40 emergency
4:24 pm
operations including working with jeremy on the ebola epidemic. never have i seen a crisis for these proportions where the scale of u.s. leadership more than this one. given the urgency and both of you have pointed to the particulars, we are focused on immediate parts. first is on vaccine, it's urgent around the world and more pressing for the fact that given conditions in india, the institute which was relied upon heavily in the early planning for vaccine response not exporting vaccine. working to increase the available to a vaccine by local producers, increase manufacturing including finance corporation companies brought online as quickly as possible on
4:25 pm
vaccine sharing by the present and very hard work with our allies to ensure other countries increase their dose sharing. we've been focused and jeremy will say more on this on vaccine readiness to make sure healthcare workers and the healthcare systems are ready and able to deploy the vaccine as they become available. we've got three responses if you think about it. the first urgent on vaccines humanitarian response, the second what might be called the shuttle pandemic, we've seen an impact on health, hiv and aids for example, there have been challenges, i'm glad to report the theft of programming to ensure continuity here and overcome challenges that come from temporary lockdowns with people getting their treatment. security is going to get worse
4:26 pm
with anticipated increase in commodity prices we've seen job losses in the poorest countries the entire sectors and at the macro level, led me countries are facing distress with challenges and potential. for these reasons, the work that's being done, i'm proud to have discussed this, not only in the immediate response but to bolster money and existing development budget is critical. it's taken a lead on the issuance of new round of special dry rate which will ease economic pressure and prevent many countries from this. the third level of response on global health security, this is urgent, this is where we have to build a foundation so we do not repeat what we've seen over the
4:27 pm
last 16 months. we are working on forefront, the first is performing existing institutions but also modernizing because our challenge is not just reform but ensuring who is fit for purpose for the challenges we know we are going to see in the future. the second is long gone, many countries signed up the international health regulation, too many have failed on these specifics and undertake these steps. we learned after ebola that there was a willingness of countries resources including the global health security in which the united states to build capacity in countries to prevent response. our challenge now and we are working actively as the state department in tandem with other countries to determine how we
4:28 pm
can finance this for the long term. any country that doesn't have capacity provides an opening for viruses like covid. our challenge is to find sustainable funding and sustained political commitment. fourth, the key area of governance, transparency and accountability. we must have transparency to understand this or any other buyers, we must have accountability in government sign on to rules and norms and we need governance to allow us to coordinate and collaborate when these crises occur. this is belonging, it requires urgency but same power but we need the support of congress to do this work overtime. all of these things and getting to the title of this hearing requires u.s. leadership. u.s. leadership i've seen mean a
4:29 pm
number of things. it means in a "humanitarian crisis" is emergency, where most of the first to arrive in the scenes throughout my career countries and community's remember this. it means we build coalitions and we leverage. we've been actively engaging our partners around the world but also mobilize resources, secretary of state launched an effort to mobilize $2 million and i'm pleased to report we've surpassed the goal of mobilizing $2.4 billion. it means the u.s. provides a vaccine, not to twist anybody's arm but it's the main tool trending in this pandemic. u.s. leadership will require
4:30 pm
sustained support. as we've seen in the case of hiv, over almost 20 years, america has stood fast administration to bring the epidemic to an end and literally millions of people around the world and lastly the support of the american people who i believe no america's leadership in the world matters but also know this is a matter of their own health and security. to work on all of these funds we've developed a plan, with your permission, i'd like to let my colic walk through this. >> thank you, i appreciate that. thank you for your testimony. >> thank you so much.
4:31 pm
all members of the subcommittee for your attention and support to usaid and state department and administrations response to the international aspect of the cupboard pandemic. want to particularly thank congress for the generosity shown in passing the american rescue plan to reinforce the work we are doing globally building on the work the government began last year to fight the global pandemic. at underscore what my colleague said about the complexity and difficulty the crisis is demonstrating. in my career in-and-out of public service at the international disasters like the humanitarian response, i've worked on development programs, i've never seen anything quite
4:32 pm
like what we are witnessing with this pandemic today. it is a triple crisis. it is obviously a health crisis spurring a "humanitarian crisis" and development crisis. there on their own, it would be historic on their own right. the three of them together pose a challenge and call for american leadership that would be unprecedented in our generation the fighting this will take an enormous effort so i will walk through the elements of the response plan the administration has put together and as gail said, the first element is fighting the virus itself so we will do that through two major objectives. the first is around scaling and accelerating access to safe and effective vaccines. this is beginning dose sharing with initial 80 million doses
4:33 pm
the president has now shared around the world. particularly so providing support and our neighbors in the region. it's announced a collaboration with a producer in india that will scale up vaccine production for global markets and in africa they've announced a week or two ago in collaboration with other department finance programs around the world. we are also investing country readiness to distribute vaccines is a crucial part of what we will be doing with our forthcoming programming because ultimately someone is not made safe by a dose in a bottle, it's
4:34 pm
safe in the arm. they're looking at the supply chain on the front end to the administration and it gets the dose into the arm. we recognize vaccines are going to take a wild to scale up globally and we are going to work very hard to get to global vaccine access next year but in the meantime as we see in south asia the virus can do a lot of damage especially as it's an increasingly dangerous area as he emerges and evolves. our second objective is to continue pushing hard and double down on the immediate support to health systems and public health interventions that save lives in the months ahead and this is through things like protecting health workers and ppe, provision of testing and diagnostic support, enhancing access to medical oxygen which is the most crucial life-saving intervention, a range of things like that that will save lives in the immediate term while we are simultaneously pushing hard on vaccines will begin coming
4:35 pm
online later this year into next year. they are simultaneously focusing on the shadow pandemic, all the other forms of human impact, secondary effect for many, the primary effect they feel and things like disruption to education. 90% of learners around the world last year were having their education obstructed. humanitarian need, enormous impact for famine in multiple countries and households scale economic distractions and the first increase in extreme poverty in about 25 years. at the same time, we are focused on systemic risks, we seen risks to closure and civil society space using public health measures covered for closing democratic activities so we are
4:36 pm
focused on that as well and the fifth objective is to build back future architecture we need for reforms to international institutions and billing procedures and tools for keeping the world safe from the next pandemic. i will stop there but happy to say more. >> will have a chance to get into the back-and-forth in the q&a but i'll recognize numbers five minutes each and health rules all-time yielded for the purposes of questioning our witnesses. because of the virtual format of this hearing, i'll recognize numbers by seniority alternating between majority and minority that can only call on you if your present with your video on. if you miss your turn, let our staff know and we'll circle back to you and if you seek recognition, unmute your
4:37 pm
microphone and address the chair verbally. before i recognize myself the question, i will remind everyone, did you go to the layout function in the top right of your screen and go to with you, you can follow the timer on the five minutes. otherwise will make me be rude and cut you off after five minutes so please, everybody trying to follow the timer so we can get everybody questions in in a timely fashion. i'll recognize myself for five minutes. the megan rescue plan contains roughly $4 billion for usaid and $3.5 billion for global funds when you combine the different accounts. this funding is critical to address secondary parts of the pandemic which are expensive. given the urgency, i'm concerned of you details where and when the funding will go out the door so i wanted to ask you, how will the funding prioritize to address secondary effects of covid such as international disaster leave, food security and health activities and when
4:38 pm
you expect it to get into the field? you expect crowdfunding and plans to fully reverse covert effects on poverty, nutrition or education? what is the full gap between where we are and where we need to be in the international response? >> thank you for that question, it's an incredibly important issue and i'm glad you are focusing on the secondary impact because this is primary for so many people around the world. we are already beginning to address the impacts through use of the funding, we have begun programming support to humanitarian response that began earlier this spring to address first and foremost acute food insecurity around the world so we use this as well as title to food commodities appropriated to
4:39 pm
begin targeting critical gaps in food security pipelines that risk undermining food deliveries critical places like yemen, ethiopia, afghanistan. as we go forward, we are also on the cusp of initiating an extension and expansion of our work around vaccine readiness and health systems and exploring in consultation with the state department and treasury department to address other nonhealth impacts of the pandemic and we are still determining how we will divide resources within the administration on secondary impacts but internal planning identified significant needs around economic support at the household level, economic support at the macro level as well and the role of the
4:40 pm
treasury department and financial institutions is important the end education and food security and we have seen significant food security impact outside of humanitarian settings tied to often to economic impacts so in terms of your question on the gap, i'd say two things, first, there is certainly more need in the world than any one government can carry along so we will orient our resources toward this but we are also encouraging others to join us in addressing these gaps but also the degree to which is a gap between resources will be depending on how long it runs. we also touch on secondary as much as possible. the size of the cap ultimately will depend on how long the pandemic is.
4:41 pm
>> one more question, is we've committed a lot of money to buy vaccines, there's some reports you may not be able to confirm yet about another big purchase, vaccines to provide to the world but as you know, it's not just about the vaccines themselves, it's also about getting the vaccines into arms and i think it's the democratic republic of congo already returning 1.3 billion doses from kovacs because he can't administer them before they expire so how do we make sure we have infrastructure set up to actually get the vaccines into arms? otherwise they are just going to spoil. >> two things, we need to make sure we calibrate liveries to what countries are ready to move and i think in a way it's a success story and that the vaccines were identified as being surplus and they could still be used elsewhere. it's critically important so
4:42 pm
obviously there are major gaps and i was oncologist earlier today with the leaders of the vaccine initiative were identified this but we also need your help with delivery that's going to be a priority focus for our next round of investments. >> thank you. i'm going to keep myself on time and we have the ranking member of the full committee from texas so i'm going to go to him next for his question. >> thank you for allowing me to be here today. i want to thank dale and jeremy for taking the time to discuss ongoing spots efforts state department and usaid. gail, it's great to work with you at the one campaign and i'm glad to see you in this new role you have. while the situation has improved
4:43 pm
here in the u.s. uncovered, the pandemic rages on in developing countries. the economic political and physical impacts of the virus are putting countries and regions already fragile at risk of further destabilization. deeply concerned of the chinese communist party, cover obstructive on early corrupt efforts projecting, influence and extract political concessions. i understand the ccp is demanding throughout this recognition of taiwan in exchange for cinemax. this information campaign seeks to undermine public confidence in u.s. manufacturing vaccine. robust less engagement is urgently needed to push back on these efforts and support partners and allies in their time of need. as a foreign affairs committee, as the committee has always had
4:44 pm
an important response ability to conduct oversight, over the $10 billion provided to the state and usaid for the american rescue plan, we owe it to the american taxpayers and people around the world in desperate need of lifesaving aid to ensure american dollars and clearly planted advancing u.s. strategic efforts. the devastating public search in india and south east asia forecast a potential consequence elsewhere in the world if we do not urgently scale up the vaccine production and tradition. last week i noted the white house announced plans to allocate 25 million vaccine doses. moments ago we saw reports the white house will buy 500 million doses of pfizer vaccines to donate around the world. beginning my question is to dale, can you describe the
4:45 pm
process taking place to determine which countries are receiving vaccine and what criteria is being used and to the panel as a whole and second, i want to draw your attention to exciting news from my home state in texas through partnership with texas children's hospital college of medicine, there vaccine just reached phase three clinical trials in india and if all goes well, they could reach middle approval by fall. it's an advanced purchase order of 300 million doses by the vaccine. i want to commend both doctors and 13 for their work. if you could comment on that effort as well as agency criteria for the vaccine. >> sure. thank you and thank you for your
4:46 pm
kind words and congrats, we saw the news about the phase three trials and i think was really critical here as it underscores observations of an american ingenuity, the more vaccines ultimately available, the better it will be and i will share with you that is been mine and jeremy's experience that despite the moves of china or russia to use this information to undermine the views of these and other vaccines, it's been our experience the demand is overwhelmingly for vaccine and which people have confidence for both safety and efficacy. on the allocation of the 25 million vaccines which is the first of 80 million, it's been a robust and engaged interagency response, all have been engaged. the criteria there were mainly
4:47 pm
three. this is a start and our aim is to end the pandemic as quickly as possible so we wanted global coverage and a focus on latin america, asia and africa. the second is to look at countries nearing a surge, at risk of search and where we could argue even though the urgency is dominant much everywhere that there is perhaps greater urgency and the third is the desire to be responsive to the request with had including to our neighbors and it was on that that we made the decision for the allocation of the first 25 million lives underscore is just the beginning. >> jeremy. >> on the vaccines from texas children's hospital, we are
4:48 pm
looking forward to seeing the results but it's certainly encouraging data, the phase one, phase two trials and we welcome and are really happy to see additional tools that come into the toolkit on the vaccine front, the more effective vaccines, especially those at low cost and easier logistics i think the better for vaccinating the world so we are encouraged. >> thank you and i yield back. >> thank you. we will not go to the vice chair of our subcommittee, jacobs of san diego. >> thank you, mr. chair and gail and jeremy, is great to see you both, thank you for being here. i was glad to hear reports of the 500 million doses of pfizer provided i think it's a very important step, i hope the reports are true but they fall short of the 11 billion doses needed to vaccinate the entire
4:49 pm
world and it's going to take a long time, enough time for potentially dangerous bearings described. to address this in the quickest way possible, we are going to need to turn our attention significantly ramping up manufacturing capacity and i appreciate the administration support to the wto but we get to reach consensus as a wto and also questions surrounding corporations from manufacturers providing know how to outside. could you describe the administration's plan to address this manufacturing issue worldwide beyond this. >> sure, let me say a couple things and then i will turn it over to you. you are right that increasing the supply, the volume is so we are working with producers to increase production for this year end wrap that up. second, this issue of
4:50 pm
manufacturing, which jeremiah and i mentioned to the corporation is key in the india initiative, we believe it will be brought on by the end of the year and we are looking at other options where again we can bring doses online before the end of the year and first and second quarters of 2022. the third and fourth thing, one is mobilizing more resources for kovacs which we been able to do by using generous contributions to leverage support for others and we are pleased the secretary kicked off and surpassed its goal. as you know the g7 summit is coming up, we been engaged members who have development finance institutions and the the ability both to share more of themselves which we are encouraging all members to do but also to increase their investment so we can ramp up
4:51 pm
production so we are working on all of it to get as much supply out there as we can as quickly as possible. >> i would add to that as we think about how we get as many shots in arms as possible by next year, we think about this as four pieces. the first piece outlines the strategy, what are the doses that can get us there and how we best combine different attributes of the different vaccines available taking into account how scalable they are, bottlenecks and so on in order to get the to have a strategy for coverage. the second is we have manufacturing capacity globally in order to do that. what we are seeing now is the biggest bottleneck at the moment not production capacity and inputs to feed that capacity so one of the things we did in
4:52 pm
april when announcing support for india, they were experiencing a surge there, rerouting the production used for astrazeneca here in the u.s. to produce it there and amplify productions so we are looking at strategies both for expanding available apply of inputs but also trying to optimize across different doses and make sure we get it from the supplies exists. the third is financing a list of u.s. support to kovacs fundraising we've been helping to do is another $2.4 billion raised in the last few weeks. >> i'm going to cut you off but the financing is really important, i appreciate you going over it. we know this is not going to be the last pandemic that this is probably something we are going to see recur more often.
4:53 pm
an article in medicine recently proposed a governmental panel at the un to tackle some of this question in a systemic way. i was wondering if the administration has looked into this, is it planning on pushing for that or what we are doing to support and undertake systematic the pandemic so we are better prepared in the future? >> great question, we have only a few seconds. there are some great recommendations like that but we are looking at this, clearly we need much better mechanisms and tools for collective action for the surveillance, we are looking at all recommendations. >> great, thank you. i yield back. >> thank you. we now go to ranking member of the subcommittee, ranking member million talkers. >> thank you very much. the question about the vaccine division, or to shift to talk about the supply chain.
4:54 pm
i was wondering if our speakers could give us insight into existing challenges right now with regard to global supply chain in general, i did see yesterday a cluster of infections in the factory in taiwan temporarily shut down operations in one of the world's largest chip companies and concerns all of us and i wanted to see the latest you had on some of the examples of how we are being affected both domestically and international global community is being affected by these disruptions. if it's playing into your decision making regarding vaccine distribution. >> let me say a couple things and thank you for the question. we are seeing disruptions like this in the pandemic all over the world in all sectors and it's one reason even as we do everything on response, we are
4:55 pm
with our partners strongly urging that they take this to protect people so we see fewer distractions. i think the disruptions do occasionally disrupt supply for vaccine. the most example in india where a breathtaking search has meant doses anticipated from the institute are now going to india so those disruptions is something we can't necessarily plan for but we need to assume are going to be part of what the world looks like over the next 18 months. that's why the emphasis on increasing supply in every possible way we can. >> not so much -- i wasn't necessarily talking about the impact on the supply of vaccine but the supply chain in general. >> okay. >> other particular countries you are seeing, the cost of --
4:56 pm
for example lumber has gone up tremendously and some of the technology parts in taiwan, you're seeing a more general question not related to the vaccine. >> yes, we are seeing is not supply chains all over the world and the main thing on that, that lends itself to the urgency of bringing the pandemic to a close as quickly as we can and moving as many vaccines we can while pushing others to do it is only when we can shutdown this space in which the virus can flourish and replicate and mutate can we protect the supply chain and other critical issues. >> okay and that's a good answer and jeremy, if you would like to add anything. >> what we have seen in india the past few months, we've been consulting regularly with u.s.
4:57 pm
businesses. my boss met recently with the ceo, made corporations in the u.s. chamber, one thing they have been underscoring is how much so many american businesses rely on india for so much of their functions for the supply chain function, it and so they were seeing disruptions to their u.s. business processes based on that and i think it's a interconnectedness you are talking about the importance of targeting this is a global problem, not a problem any one country can do so i'm glad you're underscoring that it is resident with what we are seeing and hearing. >> i was continuing to reinforce the need to make sure those countries we see a particular disruption in our supply chain
4:58 pm
are looked at as a priority to make sure we can get our economy back on track and also help other countries as well and i appreciate both your answers. >> thanks so much. >> thank you, ranking member and now congressman sherman of los angeles, california. >> thank you. this disease is the greatest catastrophe to hit the globe in 1940s. forty counted 3 million deaths. that for the world, that's just the beginning and doesn't count those health have been permanently injured, those whose education has been permanently derailed and enormous economic consequences and poor countries, economic destruction can lead to death as well. the world is focused on the cost of this outbreak. there are five possible ways to
4:59 pm
look at it. either it had nothing to do with the wuhan neurology lab was a lab was dealing with bad viruses, didn't know how to modify the virus but it just happened to escape from the lab and of course we have the 2018 report of the state department saying the lab was dealing with the virus, being sloppy about it. the third possibility is the lab actually modified, research the virus and then it escaped. the fourth is the lab was working on a bio weapon and through negligence of escape, the fifth possibility and only possibility i dismissed is the virus was modified and deliberately released on the world. the last administration first accepted everything president xi jinping said and then attacked the who for what he said.
5:00 pm
the difference is the who has no intel function, it can't see through any communist party. the congress provides over $80 billion for intel community. ... we have got to make sure we talk to the manufactures and treat them as if they expect to
5:01 pm
be treated. i know that they are making a lot of money but there are many manufacturing whose vaccines fail and they took that risk and it's probably going to litigation as a result of this statute and all we did and so the chance to lose money in the next pandemic is certainly there. we may need to facilitate the fact that manufactures of additional vaccines hopefully we will not do so in a way that causes members not to be on board next time we need them. our witnesses have already covered the importance of manufacturing new vaccines as quickly as possible. one other thing is to avoid wasting vaccines. back in december i focused on
5:02 pm
the fact that they were throwing away the pfizer and moderna vaccine after five doses even though where there were 6.5 to seven doses in the bottle. the other issue is whether we are suggesting that this is more valuable than liquid gold. there is substantial medical research that says the dosage of those at 55 is twice as many drops and i talked to dr. fauci about this and this his attitude seemed to be well this won't affect america. but it certainly affects the world so i asked our witnesses are you aware of any research being done to determine whether we are in effect wasting half
5:03 pm
the vaccine and to determine whether it would be safe and good. >> let me quickly answered by may and thank you for the question. there is ongoing research and there has been for some time now on all of these vaccines in the dosages and storage and we are following all that research when we get definitive data that shows it safe and efficacious but make modifications so there's a constant watch on all of that research. >> the gentleman's time has expired. thank you. next will go to congressman darryl issa of california. >> thank you and i appreciate congressman sherman's question because i think those are the kinds of things that are really going to allow us to be quicker
5:04 pm
so hopefully that's something in which we can close the loop on as quickly as possible. following up so when we look at the parties there was in her rear question which i ask the secretary of state earlier but i want to go through this again. china has used the vaccine as a weapon of diplomacy at times. as a result countries to recognize taiwan for example are finding themselves without a vaccine. what can we and how should we ensure that those that we effectively strong-arm the scale of justice are as great or greater than those who resist. >> thank you for the question. i think we can -- we are clearly
5:05 pm
been clear in the president has been clear that we will not use vaccines as you suggest in the case of china as a weapon and i think in stark contrast to some other countries, countries recognize that the united states is doing this in the pandemic and it's a way that makes a significant their friends. in terms of how we allocate these vaccines to ensure that we can get as much reach as possible. heck i appreciate that. mine was a more nuanced question. it was simply are we in a position, do we have or can we have a policy that recognizes the deficit made by not being with china and offsetting it?
5:06 pm
certainly you would recognize that the country got -- from china they might need less initially but if the offset of can we treat them equally when one has been denied? spent congressman i would say that i think what gives china leverage right now or has given china -- is the scarcity and the more we can address the scarcity problem which we can do by sharing the dosage we will be the largest share of doses by a large margin and we will continue to build on that fire support to covax and the funding that we have put in to continue additionally putting in. that would withstand the doses that are not dependent on china and the other countries can turn to the u.s. and the less the
5:07 pm
china has leverage with its doses our work with more vaccines puts pressure on china and reduces their space in their political position. >> one follow-up question and by definition we don't want to be heavy-handed. on the other hand it does in the armed of someone who drives a truck from town to town in a developing country is more valuable than it does for somebody who never moves around and did does or two doses in some cases into the arms of somebody who's going to travel internationally is more valuable than somebody again who stays in a single town. what are we doing to facilitate those kinds of decisions that move forward those decisions in addition to health care workers
5:08 pm
and the others that would ordinarily be the first to receive a dose? >> there's a really active research process and strategy going on right now within our government between our government and the world health organization and others when it comes to dosing strategy and it was my response represented jacobs as well but that's the right kind of question congressmen. the way we think about this is summer it's what we have done in our own country and certainly health care workers take the highest risk you should -- starting with the elderly and those with comorbidities and then you shift to try and vaccinate on a transition skill. >> thank you. i yield back. >> thank you congressman i said. we will go next to congress
5:09 pm
within -- congresswoman houlahan of pennsylvania. >> thank you and thank you all. [inaudible] i had a question i wanted to follow up with in the last conversation about our ability to mandate how countries are allocating and i had a conversation this morning and is there anything that we can be doing to be more effective with the limited dosing that we do have? >> every country that participates in a covax platform which is really every low and middle income country in the world has to prepare and submit
5:10 pm
for review by covax and the w.h.o. national deployment and vaccination plan which lays out how the country will prioritize all the search of things that the congressman is asking about. how will the country. tesla systems have been put in place and so those plans depend on the strength of the government and the country like india is going to have a stronger plan than the country -- for example that those plans to give us insight and accountability for how those vaccines will be used to create a benchmark for success. we are also providing a significant amount of technical assistance that we will be expanding in the months ahead as we have the programming in the
5:11 pm
area. it supports government in targeting and enables them to have the kind of logistics in distribution architecture that they need and to support things like monitoring so that. >> programs like pepfar are part of this coordinated response. absolutely and pepfar is a great platform for what we'll be doing in much of that country. >> inc. you my question had to do with the impact but is having on the women in the world and their economic security. women may not be able to return to work and have childcare responsibilities and school closures in this kind of thing. how can we in the u.s. leverage
5:12 pm
our investment internationally and globally to respond to this threat globally collects >> it's a really good question and thank you for asking. whether it's pepfar or usaid or other programs worries that a disproportionate number of children out of school and women facing obstacles in the workforce including childcare and [inaudible] all of those things are factored in to our response as a secondary response that we can start helping countries recover. to be fair i think women are going to feel the undue burden of this for longer than men because of some of these are structural but to try to bring education into her programming
5:13 pm
emphasized getting gross back. as we are looking at the collapse of small and medium enterprises in the country we take a particular focus on the impact it's had on women and the programs can be devised to account for that. >> i don't know how much time i have left but my next question has to do with its educational program and in distance learning and all those kind of things. how can we -- what have we learned from this time we are experiencing in [inaudible] >> absolutely something we are thinking about and working on. in our work we have provided $900 million worth of education programming that touched on
5:14 pm
covid bolstering new funding and funding from existing educational programs in one of the things we have been investigating in its support for morgan -- remote and distant slow burning if that's an option so schoolchildren can have recourse words technically feasible. >> thank you. we will now go to representative came from new jersey. >> thank you chairman and ms. smith and mr. konyndyk is so great to see you and i can tell you -- [inaudible] >> i think represented came maybe having some connectivity issues. let's see if we give them a few seconds to get back on.
5:15 pm
are right you all while we wait for andy to get his connection in better shape why don't we take a second round questions now because i think that completes first round of questions. again for the members don't feel compelled to ask questions on the second round take the opportunity for something you're dying to ask that you didn't have a chance and this will be an opportunity. i will begin with the question here and if you've got a question members please have your staff reach out directly to our committee staff so they can let me know who is in the queue on second round questions, okay? all right. i wanted to ask you all about the u.s.-mexico border communities. the biden administration recently announced they will share 1 million covid-19 vaccines with mexico and many of these doses will go to communities at the u.s.-mexico
5:16 pm
border. the mexican government has said most of those doses will go to caribbean hotspots such as cancun. while i agree it's important to share doses with workers in these regions i'm also concerned border communities will be left out or not prioritize. how much input is the united states have enough where we would like vaccines donated to be used within a particular country and how are you prioritizing committees like health care workers and what is the united states doing to help the over 1 million american citizens who live in mexico get access to these vaccines? >> on this issue how we country -- is based on their plan.
5:17 pm
countries with which we have a robust dialogue. i can look into that and follow up on the specifics. that is our main approach to that. >> i am not familiar with that issue but in general we are urging countries to prioritize health care workers first and we are ultimately giving countries control of their own vaccine distribution. it's something we can look into further and follow up with. >> my concern is either the donor nation including the united states are covax or somebody has to set up some rules for the road even if as we are doing it we turn it over to those countries and say
5:18 pm
distribute it, deliver it and executed according to your own plan but who is checking and are overseeing that in making sure it's successful in what they are doing. bear in mind if we turned over to them will we let me ask this before you turn it over to them today submit their plans to us so that we can review what their plan of operation is? >> in the case of mexico know. they are within the consortium is self financed country so basically they are using covax as a german mechanism but they are paying for their own vaccine so they are the threshold is lower because it's not donated material from covax. >> we are donating our vaccines and there have been consultations through the embassies and i don't know how detailed it's been on targeting vaccines but we can check it and
5:19 pm
follow-up. >> okay and i have to reiterate and i know you are all working hard and doing your very best and we all support the same goal but i would impress upon you all we have to do everything possible to make sure especially the countries that are receiving donations from around the world that they are executing on their plan that they are vaccinating people in a smart way otherwise my fear is we will be here year from now or two or three years from now and there will be all these things in the press about how this nation received 10 million doses and only 2 million of them were used. that is my fear and less there is some real oversight of what's going on. >> i think that's a very good point and something we are very focused on. the case of mexico that is true but in the case of many countries when it comes to covax as jeremy said our plan has to
5:20 pm
be technically reviewed beforehand. we have these additional benefits on the usaid presence and the presence in other countries what's gives us an assurance that we can track how these vaccine should be deployed. there've been a lot of cases looking for advice. >> and i just fear it's going to be like tax abatement for big companies that promise to create 5000 jobs and five years down the road you learn they only created 500 jobs and then you can't clawback any of those funds. anyway my time is running out but thank you all very much. i know sara has a question but it looks like andy is back so i want to get andy's technology working first. >> hopefully this time it will
5:21 pm
work a little better. i want to thank ms. smith and mr. konyndyk and it means so much to see you doing this work and he gives me great confidence in what you bring to this so thank you so much for agreeing to take on this incredibly important mission. one thing i want to hone in on it was mentioned the development finance corporation. i want to drill into that just a little bit and get a sense of where else this could be utilized or were you see us getting into. mr. konyndyk you made reference to this in different ways and i think it's an incredibly important tool for countries around the world and something that is -- and can either be
5:22 pm
speak to the role that we should play in vaccine distribution and manufacturing a broad? >> it's an absolute pleasure to see you having worked together in the past. i think it's been strengthened obviously by the bill back with strong bipartisan support across the country. that gives us additional tools and in terms of making the investment that can take local manufactures from level to the next level in terms of ali ms. absolute critical. a less direct impact on vaccine distribution is local manufactures in different parts of the world is significant. you have proximity and
5:23 pm
availability but the other point i would make usaid makes a big difference. they can make investments in things that prevent us from being prepared but if you look at local manufactures and other -- we need to make investments in therapeutic and developing countries need to more [inaudible] so it's a really vital tool and the bill back has given us that. we'd love to talk to you and others about where we can go and there's a lot of opportunity to build on this on what we have ready done and look at the
5:24 pm
landing power to be able to deal with future pandemics. mr. konyndyk i don't know if you'd like to answer. >> the dnc is playing a crucial role and we are seeing this focusing on some of the immediate scale of vaccine production that will service in this pandemic but they are also looking for that which was serving future pandemics. with the news out of india the need and importance of diversifying the manufacturing base for vaccines so that we don't just have all the vaccine production sitting in large countries that can absorb much of what they themselves but we diversify so that it's more equitably available across the globe. we have been providing financing
5:25 pm
tools to support the work of gavi that a bin important to their ability to secure a new perk here meant and i can't overstate how much the state has been lenient to help in the manufacturing input front and looking for deals to support therapeutic and diagnostic structures so very encouraging and we have had a great relationship with them. >> that's great to hear that the story we've been told more on capitol hill and elsewhere and we are trying to get a grip on the potential there in the areas which can be a force multiplier in so many different levels. mr. chairman thanks for letting me take a at it. >> absolutely.
5:26 pm
thank you and i think our final second round question comes from rappers -- representative jacobs. senate thank you very much mr. chairman. at the end of my last question we had a short time so i want to reiterate how important i think it will be to have a clear view of the risk for the pandemic so i would urge it to look into the intergovernmental panel and see where we will have allies if that's something we can do and i wanted to drill down a little more and usaid strategy to deploy non-vaccine covid assistance. similar with other development i think it's important that we are devising these plants in deciding where a development
5:27 pm
dollars are used as well as possible. wondering if you could describe local committees to understand our needs. thank as we have seen in our own country and other campaigns that local buy-in and local validation is crucial to confidence in vaccines. we are not going to get where we need to go on vaccine updates if we don't have the local buy-in so we are doing that on a few levels are on programs to invest in and support local voices and to elevate and empower validators you can reach out to their own communities as we have done in this country as well but we also take into the macro level. the vaccine sharing that the u.s. is doing in africa we are
5:28 pm
not unilaterally setting where they are going to go. we have done hard work in building support on the vaccine platform and today i was on the call discussing that platform. we are trying to do this across a couple of levels. >> thank you. those were all of my questions. >> thank you represented jacobs. thank you to all of our witnesses for testifying today and members for joining us and asking these important questions. it's important not only to the united states but also the world. 101 to the century pandemic hits the world there is no country better able to lead the national response to bring the world together against a common cause than the united states. we are only at the beginning of the fight and covid-19 i look forward to working with the administration in congress on
5:29 pm
making substantive progress and with that our subcommittee session is adjourned. thank you all. lisker but it was a high-profile aide to president johnson. she was born in texas in 1920 came to washington in 1942 as a
5:30 pm
reporter working for the american state. after her white house years liz carpenter continued her career in d.c. as an activist political humorist and public relations expert. president biden is in the uk this week for his first overseas trip. today he met with british prime minister boris johnson added that the g7 summit being held in cornwall england. >> thank you. it was a


info Stream Only

Uploaded by TV Archive on